Member Info for TRENCH123

Avocet, something about you reminds me of the song 'Do it Again' by Steely Dan

Avocet, you are always so positive. keep it up

Thanks sharepoint, all very interesting. The update to shareholders on the website has happened quicker than is normally the case

Good to see The Doc taking a bigger stake and challenging accepted placing protocol. If it results in a raise at 0.40 (or higher) instead of 0.30 then great

I am not sure PYC need the cash now anyway, rather it is more to avoid any distraction once the new CEO starts in June

Twitter posts by the Doc today have been interesting and are worth a read

His last post at the end of the trading day includes the comment '.... I sense a bigger holding maybe beneficial here'

DeBull, you make a fair point. I can only suggest that PYC are very busy

As regards ongoing work on DosemeRx and the personalised dosing software, the recent interims covered this in some detail. I was intrigued by the comment 'the evaluation of this dataset is still at an early stage, and the Company will share more information about this new data source and its effect on development in announcements planned for later in the second half of the financial year'. This advance notice of an announcement (and within the next three months or so) is unprecedented for PYC in my recollection.

As regards your comments about the placing, chess games have no place here even though it could potentially push the share price up

Maybe the Doc taking some more ?

Yes, good to see

New post from PYC major shareholder

'I sense this is the final brick in the wall for the company and it goes on and does well'

I am not unhappy with the placing, the share price deficit will be made good in the short term IMHO. There has been real progress made in the last 12 months and I expect this to continue with the new funding. To quote Pete Sargent's comments 'With this latest round of funding, investment is being made in key growth initiatives across the business to continue our growth trajectory by investing further in business development and marketing, as well as the exploration of transformational opportunities that will accelerate growth'

Not sure why we get these trivial value transactions (£1.00 etc). Should be a minimum value trade (say £50 or £100) unless the entry is to correct for a processing error IMO

Physiomics Linkedin page, under 'see jobs'

Looks like there is good interest in the CEO job with 161 applications to date. It would appear that Emily Hatchwell is no longer with PYC (think she was the last to join)

Agree entirely KH

Trout, you certainly enjoy banging away on the old tripe-writer . I see you are not content with just here, but are also filling the internet with your wisdom on that other site (which shall remain nameless) and which no one has any interest in

As AI says, 'Trout naturally face and swim against the current'. This explains everything

Be good to see Mike Witlow take another chunk

Good points made KH

Under the section relating to Personalised Medicine Dosing Software there is the news that PYC have entered into a Data Usage Agreement with a leading US University to access a substantial dataset from cancer patients undergoing trials. This to supplement data from ongoing clinical trials in Blackpool.

There is a comment which caught my eye later in the section. 'The evaluation of this dataset is still at an early stage, and the Company will share more information about this new data source and its effect on development in announcements planned for later in the second half of the financial year'

What are these planned 'announcements'. Could it be connected with the anniversary of the expanded 'Heads of Terms Agreement' with DosemeRx which would be 10th July, 2026. The DosemeRx tie up is an intriguing one, maybe some major news coming

Increased shareholding is reflected on PYC website